Miao Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Miao Jiang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Zhengyang Li
Affiliation Department of Gastroenterology, Jinshan Hospital of Fudan University, Shanghai, China
3 shared publicationsQian Hua
Affiliation Department of Gastroenterology, Jinshan Hospital of Fudan University, Shanghai, China
2 shared publicationsShizan Xu
Department of Gastroenterology, Jinshan Hospital of Fudan University, Shanghai, China
2 shared publications- Xiaoming Fan
Department of Gastroenterology, Jinshan Hospital of Fudan University, Shanghai, China
2 shared publications Yajie Wang
Department of Gastroenterology, Jinshan Hospital, Fudan University, Shanghai, China
2 shared publicationsHao Zhou
Department of Gastroenterology, Jinshan Hospital, Fudan University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 7 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0353237
Association between hemoglobin-to-red cell distribution width ratio and occurrence of sepsis during ICU stay in inflammatory bowel disease patients who died: a retrospective study using the EICU-CRD database
Background: The hemoglobin-to-red cell distribution width ratio (HRR) is a biomarker associated with systemic inflammation and outcomes in critical illness. Within clinical databases, there exists an extreme-prognosis subgroup of inflammatory bowel disease (IBD) patients, those who all died within 30 days of ICU admission. Due to limitations in the database, this study can only analyze this specific subgroup. Objective: This study aims to explore and describe the association between admission HRR and the occurrence of sepsis during ICU stay in this specific subgroup of IBD patients. Methods: A retrospective cohort study was conducted using the eICU Collaborative Research Database (2014–2015), including 229 eligible patients. Multivariable logistic regression was used to assess the independent association, adjusting for confounders. The dose-response relationship was examined using restricted cubic spline (RCS) models. Subgroup and interaction analyses were performed across age, sex, and race. Results: The sepsis group had a significantly lower admission HRR than the non-sepsis group (6.04 ± 1.66 vs. 6.77 ± 2.0, P = 0.008). After full adjustment, each 1-unit increase in HRR was associated with 20.3% lower odds of sepsis (P = 0.007). Compared to the lowest quartile (HRR < 5.1), patients in the highest quartile (HRR ≥ 7.85) had 66.8% lower adjusted odds of sepsis (P = 0.015). RCS analysis indicated a linear, inverse relationship between HRR and sepsis (P for non-linearity = 0.42). Subgroup analysis revealed the negative association was more pronounced in patients aged 0.05), indicating the association did not differ meaningfully across these subgroups. Conclusions: In this specific cohort, a lower admission HRR was associated with the occurrence of sepsis. Due to inherent selection bias, this finding describes an association within this specific subgroup and cannot be generalized. This exploratory study generates the hypothesis that HRR may reflect a unique pathophysiological state in end-stage IBD, a hypothesis that requires validation in prospective, unbiased cohorts.
- 7 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0353237
Open AccessAssociation between hemoglobin-to-red cell distribution width ratio and occurrence of sepsis during ICU stay in inflammatory bowel disease patients who died: a retrospective study using the EICU-CRD database
Background: The hemoglobin-to-red cell distribution width ratio (HRR) is a biomarker associated with systemic inflammation and outcomes in critical illness. Within clinical databases, there exists an extreme-prognosis subgroup of inflammatory bowel disease (IBD) patients, those who all died within 30 days of ICU admission. Due to limitations in the database, this study can only analyze this specific subgroup. Objective: This study aims to explore and describe the association between admission HRR and the occurrence of sepsis during ICU stay in this specific subgroup of IBD patients. Methods: A retrospective cohort study was conducted using the eICU Collaborative Research Database (2014–2015), including 229 eligible patients. Multivariable logistic regression was used to assess the independent association, adjusting for confounders. The dose-response relationship was examined using restricted cubic spline (RCS) models. Subgroup and interaction analyses were performed across age, sex, and race. Results: The sepsis group had a significantly lower admission HRR than the non-sepsis group (6.04 ± 1.66 vs. 6.77 ± 2.0, P = 0.008). After full adjustment, each 1-unit increase in HRR was associated with 20.3% lower odds of sepsis (P = 0.007). Compared to the lowest quartile (HRR < 5.1), patients in the highest quartile (HRR ≥ 7.85) had 66.8% lower adjusted odds of sepsis (P = 0.015). RCS analysis indicated a linear, inverse relationship between HRR and sepsis (P for non-linearity = 0.42). Subgroup analysis revealed the negative association was more pronounced in patients aged 0.05), indicating the association did not differ meaningfully across these subgroups. Conclusions: In this specific cohort, a lower admission HRR was associated with the occurrence of sepsis. Due to inherent selection bias, this finding describes an association within this specific subgroup and cannot be generalized. This exploratory study generates the hypothesis that HRR may reflect a unique pathophysiological state in end-stage IBD, a hypothesis that requires validation in prospective, unbiased cohorts.
- Open Access
- 30 August 2022
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (2) , 216-221
Application of endoscopic purse-string sutures in high-risk peptic ulcer hemorrhage: preliminary experience of 38 cases
This study is a prospective study to explore the therapeutic effect of endoscopic purse-string sutures in high-risk peptic ulcer hemorrhage.We prospectively collected and analyzed data from July 20...
- 30 August 2022
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (2) , 216-221
Open AccessApplication of endoscopic purse-string sutures in high-risk peptic ulcer hemorrhage: preliminary experience of 38 cases
This study is a prospective study to explore the therapeutic effect of endoscopic purse-string sutures in high-risk peptic ulcer hemorrhage.We prospectively collected and analyzed data from July 20...
- Open Access
- 26 July 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13
LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway
Objective: Non-alcoholic fatty liver disease (NAFLD) can be attributed to the dysregulation of hepatic lipid metabolism; however, its cellular and molecular mechanisms remain unclear. This study aims to explore the effect of long non-coding RNA growth arrest specific 5 (GAS5) on hepatic lipid metabolism in fatty liver models.Methods: Obese mice, high fat diet-fed mice and free fatty acid-stimulated cells were used for GAS5 expression detection. GAS5 overexpression or knockdown models were established to elucidate the regulatory function of GAS5 in de novo lipogenesis (DNL) and mitochondrial function. Bioinformatic analyses and dual luciferase assays were used to investigate the interaction between GAS5, miR-26a-5p and phosphodiesterase (PDE) 4B. The involvement of the cyclic adenosine monophosphate (cAMP)/cAMP-response element-binding protein (CREB) pathway was evaluated using H89 and forskolin treatment.Results: GAS5 was activated in vitro and in vivo fatty liver models. Knockdown of GAS5 reduced lipid droplet accumulation, DNL associated enzymes and preserved mitochondrial function, while GAS5 overexpression exacerbated hepatic lipid accumulation. Mechanistically, GAS5 sponged miR-26a-5p to increase PDE4B expression and subsequently modulated DNL and mitochondrial function via the cAMP/CREB pathway.Conclusion: Downregulation of GAS5 can activate the cAMP/CREB pathway through miR-26a-5p/PDE4B axis to mitigate hepatic lipid accumulation. This study provides evidence that downregulation of GAS5 may be a potential therapeutic option for the treatment of NAFLD.
- 26 July 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13
Open AccessLncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway
Objective: Non-alcoholic fatty liver disease (NAFLD) can be attributed to the dysregulation of hepatic lipid metabolism; however, its cellular and molecular mechanisms remain unclear. This study aims to explore the effect of long non-coding RNA growth arrest specific 5 (GAS5) on hepatic lipid metabolism in fatty liver models.Methods: Obese mice, high fat diet-fed mice and free fatty acid-stimulated cells were used for GAS5 expression detection. GAS5 overexpression or knockdown models were established to elucidate the regulatory function of GAS5 in de novo lipogenesis (DNL) and mitochondrial function. Bioinformatic analyses and dual luciferase assays were used to investigate the interaction between GAS5, miR-26a-5p and phosphodiesterase (PDE) 4B. The involvement of the cyclic adenosine monophosphate (cAMP)/cAMP-response element-binding protein (CREB) pathway was evaluated using H89 and forskolin treatment.Results: GAS5 was activated in vitro and in vivo fatty liver models. Knockdown of GAS5 reduced lipid droplet accumulation, DNL associated enzymes and preserved mitochondrial function, while GAS5 overexpression exacerbated hepatic lipid accumulation. Mechanistically, GAS5 sponged miR-26a-5p to increase PDE4B expression and subsequently modulated DNL and mitochondrial function via the cAMP/CREB pathway.Conclusion: Downregulation of GAS5 can activate the cAMP/CREB pathway through miR-26a-5p/PDE4B axis to mitigate hepatic lipid accumulation. This study provides evidence that downregulation of GAS5 may be a potential therapeutic option for the treatment of NAFLD.
- Open Access
- 2 February 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (2) , 1-13
LncRNA FIRRE functions as a tumor promoter by interaction with PTBP1 to stabilize BECN1 mRNA and facilitate autophagy
Long non-coding RNAs (lncRNAs) play critical functions in various cancers. Firre intergenic repeating RNA element (FIRRE), a lncRNA located in the nucleus, was overexpressed in colorectal cancer (CRC). However, the detailed mechanism of FIRRE in CRC remains elusive. Results of RNA sequence and qPCR illustrated overexpression of FIRRE in CRC cell lines and tissues. The aberrant expression of FIRRE was correlated with the migration, invasion, and proliferation in cell lines. In accordance, it was also associated with lymphatic metastasis and distant metastasis in patients with CRC. FIRRE was identified to physically interact with Polypyrimidine tract-binding protein (PTBP1) by RNA pull-down and RNA immunoprecipitation (RIP). Overexpression of FIRRE induced the translocation of PTBP1 from nucleus to cytoplasm, which was displayed by immunofluorescence and western blot. In turn, delocalization of FIRRE from nucleus to cytoplasm is observed after the loss of PTBP1. The RNA-protein complex in the cytoplasm directly bound to BECN1 mRNA, and the binding site was at the 3' end of the mRNA. Cells with FIRRE and PTBP1 depletion alone or in combination were treated by Actinomycin D (ACD). Results of qPCR showed FIRRE stabilized BECN1 mRNA in a PTBP1-medieated manner. In addition, FIRRE contributed to autophagy activity. These findings indicate FIRRE acts as an oncogenic factor in CRC, which induces tumor development through stabilizing BECN1 mRNA and facilitating autophagy in a PTBP1-mediated manner.
- 2 February 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (2) , 1-13
Open AccessLncRNA FIRRE functions as a tumor promoter by interaction with PTBP1 to stabilize BECN1 mRNA and facilitate autophagy
Long non-coding RNAs (lncRNAs) play critical functions in various cancers. Firre intergenic repeating RNA element (FIRRE), a lncRNA located in the nucleus, was overexpressed in colorectal cancer (CRC). However, the detailed mechanism of FIRRE in CRC remains elusive. Results of RNA sequence and qPCR illustrated overexpression of FIRRE in CRC cell lines and tissues. The aberrant expression of FIRRE was correlated with the migration, invasion, and proliferation in cell lines. In accordance, it was also associated with lymphatic metastasis and distant metastasis in patients with CRC. FIRRE was identified to physically interact with Polypyrimidine tract-binding protein (PTBP1) by RNA pull-down and RNA immunoprecipitation (RIP). Overexpression of FIRRE induced the translocation of PTBP1 from nucleus to cytoplasm, which was displayed by immunofluorescence and western blot. In turn, delocalization of FIRRE from nucleus to cytoplasm is observed after the loss of PTBP1. The RNA-protein complex in the cytoplasm directly bound to BECN1 mRNA, and the binding site was at the 3' end of the mRNA. Cells with FIRRE and PTBP1 depletion alone or in combination were treated by Actinomycin D (ACD). Results of qPCR showed FIRRE stabilized BECN1 mRNA in a PTBP1-medieated manner. In addition, FIRRE contributed to autophagy activity. These findings indicate FIRRE acts as an oncogenic factor in CRC, which induces tumor development through stabilizing BECN1 mRNA and facilitating autophagy in a PTBP1-mediated manner.